Detection of allergen-specific ige
CA 2429372 A1 · Owner: Radecki, Steven V. · Inventors: Mccall, Catherine A.; Radecki, Steven V.; Babu, Uma Mahesh
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to point-of-care devices and methods to screen animals with suspected IgE-mediated allergic disease. The present invention provides a simple and rapid preliminary immunoassay screen in which a defined mixture of , clinically relevant allergens is used to capture allergen- specific IgE present in a sample, followed by a second binding reagent that selectively binds IgE. The present invention further provides methods for prescribing immunotherapy treatment in animals having IgE-mediated diseases. Devices and kits useful for carrying out the methods of the invention are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.